PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 26, 2026ACG Case Reports Journal0 citationsOpen Access

Diagnostic and Therapeutic Challenges in Seronegative Autoimmune Hepatitis With Concurrent Graves Disease and Immune Thrombocytopenia

View Full Paper
BMBlake McLeodRotorua HospitalNWNirbaanjot WaliaThe University of MelbourneVRVikram Rao

Key Points

  • The study aims to explore diagnostic and therapeutic challenges in managing seronegative autoimmune hepatitis alongside other autoimmune disorders.
  • Discussed complications related to diagnosis and management of concurrent autoimmune conditions.
  • Performed transjugular liver biopsy to confirm diagnosis post platelet transfusion.
  • Administered intravenous glucocorticoids for autoimmune hepatitis and immune thrombocytopenia.
  • Managed hyperthyroidism through graded escalation of carbimazole.
  • Successful diagnosis of seronegative autoimmune hepatitis after liver biopsy.
  • Effective management of immune thrombocytopenia with glucocorticoids.
  • Hyperthyroidism was controlled with carbimazole therapy.
  • Illustrated practical strategies for concurrent autoimmune conditions amid competing health risks.

Abstract

Abstract Autoimmune hepatitis (AIH) is commonly associated with extrahepatic autoimmune diseases. We discuss the challenges in managing a novel case of seronegative AIH occurring simultaneously with Graves disease and immune thrombocytopenia. Diagnosis was complicated by severe thrombocytopenia delaying liver biopsy and the challenge of managing thyrotoxicosis with antithyroid medications in the setting of acute hepatitis. We were able to safely perform transjugular liver biopsy to confirm AIH, after platelet transfusion. AIH and immune thrombocytopenia were treated with intravenous glucocorticoids, and hyperthyroidism was managed with graded escalation of carbimazole. This case highlights practical strategies for the diagnosis and management of concurrent autoimmune conditions with competing risks.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

McLeod et al. (2026) studied this question.

synapsesocial.com/papers/69c4ccbbfdc3bde4489182c3https://doi.org/10.14309/crj.0000000000002054
Ask AI
Helpful
Bookmark
Share
View Full Paper